Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.57 |
| ▸ | CA1 | P00915 | 4/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27486062 | 0.98 | CA2 (0.55) | CA2CA1MAPK1CPB2SLC1A3 | |
| SCHEMBL21052329 | 0.98 | CA2 (0.55) | CA2CA1MAPK1CPB2SLC1A3 | |
| SCHEMBL28301437 | 0.98 | CA2 (0.55) | CA2CA1MAPK1CPB2SLC1A3 | |
| SCHEMBL7913384 | 0.96 | CA2 (0.53) | CA2CA1MAPK1CPB2SLC1A3 | |
| SCHEMBL18837210 | 0.96 | CA2 (0.53) | CA2CA1MAPK1CPB2SLC1A3 | |
| SCHEMBL9000340 | 0.94 | CA2 (0.57) | CA2CA1MAPK1CPB2SLC1A2 | |
| SCHEMBL28793337 | 0.94 | CA2 (0.57) | CA2CA1MAPK1CPB2SLC1A2 | |
| SCHEMBL3312232 | 0.94 | CA2 (0.57) | CA2CA1MAPK1CPB2SLC1A2 | |
| SCHEMBL18143477 | 0.94 | CA2 (0.57) | CA2CA1MAPK1CPB2SLC1A2 | |
| Hydrochloric Acid SCHEMBL28630562 | 0.94 | CA2 (0.52) | CA2CA1MAPK1CPB2SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230151049-A1 | Compounds Useful in HIV Therapy | VIIV HEALTHCARE COMPANY (US) | 2023-05-18 | — | — | US | disclosed |
| US-20230151049-A1 | Compounds Useful in HIV Therapy | VIIV HEALTHCARE COMPANY (US) | 2023-05-18 | — | — | US | disclosed |
| EP-4126888-A1 | COMPOUNDS USEFUL IN HIV THERAPY | VIIV Healthcare Company (US) | 2023-02-08 | — | — | EP | disclosed |
| WO-2021194828-A1 | COMPOUNDS USEFUL IN HIV THERAPY | VIIV HEALTHCARE COMPANY (US) | 2021-09-30 | — | — | WO | disclosed |
| US-9890231-B2 | Triarylphosphine or triarylarsine compound, alpha-olefin polymerization catalyst using the compound, ternary copolymer, and production process of alpha-olefin-((meth)acrylic acid)-based copolymer | JAPAN POLYETHYLENE CORPORATION (JP) | 2018-02-13 | — | — | US | disclosed |
| US-20160264699-A1 | NOVEL TRIARYLPHOSPHINE OR TRIARYLARSINE COMPOUND, ALPHA-OLEFIN POLYMERIZATION CATALYST USING THE COMPOUND, TERNARY COPOLYMER, AND PRODUCTION PROCESS OF ALPHA-OLEFIN -((METH)ACRYLIC ACID)-BASED COPOLYMER | JAPAN POLYETHYLENE CORPORATION (JP) | 2016-09-15 | — | — | US | disclosed |
| US-9153785-B2 | Semiconducting polymers | THE UNIVERSITY OF CHICAGO (US) | 2015-10-06 | — | — | US | disclosed |
| US-9153785-B2 | Semiconducting polymers | THE UNIVERSITY OF CHICAGO (US) | 2015-10-06 | — | — | US | disclosed |
| US-9153785-B2 | Semiconducting polymers | THE UNIVERSITY OF CHICAGO (US) | 2015-10-06 | — | — | US | disclosed |
| US-20140145119-A1 | SEMICONDUCTING POLYMERS | UNIVERSITY OF CHICAGO (US) | 2014-05-29 | — | — | US | disclosed |
| US-20140145119-A1 | SEMICONDUCTING POLYMERS | UNIVERSITY OF CHICAGO (US) | 2014-05-29 | — | — | US | disclosed |
| US-20140145119-A1 | SEMICONDUCTING POLYMERS | UNIVERSITY OF CHICAGO (US) | 2014-05-29 | — | — | US | disclosed |
| CN-103619902-A | Semiconducting polymers | UNIV CHICAGO | 2014-03-05 | — | — | CN | disclosed |
| EP-2697283-A1 | SEMICONDUCTING POLYMERS | University of Chicago (US) | 2014-02-19 | — | — | EP | disclosed |
| WO-2012142469-A1 | SEMICONDUCTING POLYMERS | UNIVERSITY OF CHICAGO (US) | 2012-10-18 | — | — | WO | disclosed |
| WO-2007062198-A1 | METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY | ADVANCED CELL TECHNOLOGY, INC. (US) | 2007-05-31 | — | — | WO | disclosed |
| US-3933889-A | 4,5-Cis-didehydro-PGF1.sub.α analogs | THE UPJOHN COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230151049-A1 | Compounds Useful in HIV Therapy | CCR5, CD4, NPC1 | CA2 4540/4885CA1 4583/4885MAPK1 3677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.